Zantac in global recall over 'unacceptable' levels of potential carcinogen

Heartburn medicine pulled by GlaxoSmithKline while it investigates source of impurity

GlaxoSmithKline is recalling the popular heartburn medicine Zantac in all markets, days after the US Food and Drug Administration (FDA) found “unacceptable” levels of probable cancer-causing impurity in the drug.

Zantac, also sold generically as ranitidine, is the latest drug in which cancer-causing impurities have been found. Regulators have been recalling some blood pressure and heart failure medicines since last year. read more »

Whistleblower says Navy shipbuilders ignored nuclear submarine testing procedures for years

A recently unsealed lawsuit could explain a problem that has affected subs for more than a decade

A whistleblower has accused the country’s largest shipbuilder of ignoring the Navy’s testing and certification requirements, allegedly putting sailors’ lives at risk by degrading the stealth capabilities of U.S. nuclear submarines.

The whistleblower, an engineer named Ari Lawrence, held a senior role with Huntington Ingalls’s submarine division, Newport News Shipbuilding, until October 2017. Lawrence has not requested anonymity and made his allegations in a publicly available complaint filed under the federal False Claims Act. read more »

Former Wall Street Trader Pleads Guilty To Running A Ponzi Scheme

The United States Attorney for the Southern District of New York, announced today that Paul A. Rinfret pled guilty to participating in a Ponzi scheme in which he obtained approximately $19 million in total from victims through a variety of lies and misrepresentations.  Rinfret pled guilty to one count of wire fraud and one count of securities fraud before U.S. District Judge Gregory H. Woods. read more »